NYSE:STESteris Stock Price, Forecast & News

Steris' stock was trading at $145.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, STE shares have increased by 9.9% and is now trading at $159.64.
View which stocks have been most impacted by COVID-19.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris.

Steris PLC (NYSE:STE) posted its earnings results on Monday, August, 3rd. The medical equipment provider reported $1.31 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.33. The medical equipment provider earned $668.90 million during the quarter, compared to analyst estimates of $643.38 million. Steris had a net margin of 13.69% and a return on equity of 16.24%. The company's quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.23 earnings per share.
View Steris' earnings history.

Steris declared a quarterly dividend on Monday, August 3rd. Investors of record on Thursday, August 27th will be paid a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Wednesday, August 26th. This is a boost from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history.

3 equities research analysts have issued 1-year target prices for Steris' shares. Their forecasts range from $170.00 to $170.00. On average, they expect Steris' stock price to reach $170.00 in the next year. This suggests a possible upside of 6.5% from the stock's current price.
View analysts' price targets for Steris.

News articles about STE stock have been trending extremely negative this week, according to InfoTrie. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Steris earned a daily sentiment score of -4.1 on InfoTrie's scale. They also assigned news headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term.
View the latest news about Steris.

Steris saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 1,510,000 shares, a decrease of 12.2% from the April 15th total of 1,720,000 shares. Based on an average daily volume of 826,800 shares, the short-interest ratio is currently 1.8 days. Approximately 1.8% of the shares of the company are short sold.
View Steris' Short Interest.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR) and ABIOMED (ABMD).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Visa (V), Gilead Sciences (GILD), Medtronic (MDT), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Abbott Laboratories (ABT), Cisco Systems (CSCO) and Home Depot (HD).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris' stock is owned by a variety of retail and institutional investors. Top institutional investors include William Blair Investment Management LLC (1.44%), Bessemer Group Inc. (1.09%), Bank of New York Mellon Corp (0.94%), Principal Financial Group Inc. (0.91%), Fisher Asset Management LLC (0.79%) and Congress Asset Management Co. MA (0.74%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr.
View institutional ownership trends for Steris.

STE stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Fisher Asset Management LLC, Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., Frontier Capital Management Co. LLC, GW&K Investment Management LLC, New York State Common Retirement Fund, and Arizona State Retirement System. Company insiders that have sold Steris company stock in the last year include Cary L Majors, John Adam Zangerle, Mohsen Sohi, Renato Tamaro, and Richard Martin Steeves.
View insider buying and selling activity for Steris.

STE stock was acquired by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Retirement Systems of Alabama, Principal Financial Group Inc., Bessemer Group Inc., Alta Capital Management LLC, State of Tennessee Treasury Department, Achmea Investment Management B.V., and Winslow Asset Management Inc..
View insider buying and selling activity for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $159.64.

Steris has a market capitalization of $13.58 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

The official website for Steris is www.steris.com.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]